The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma

被引：34
|
作者：
Flores, Joan Ericka [1 ,2 ]
Thompson, Alexander J. [1 ,2 ,3 ]
Ryan, Marno [1 ,2 ,3 ]
Howell, Jessica [1 ,2 ,3 ,4 ]
机构：
[1] St Vincents Hosp Melbourne, Dept Gastroenterol, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia
[3] Burnet Inst, Dis Eliminat Program, Melbourne, Vic 3004, Australia
[4] Monash Univ, Dept Epidemiol & Preventat Med, Clayton, Vic 3800, Australia
来源：
VACCINES | 2022年 / 10卷 / 05期
关键词：
hepatitis B; vaccination; hepatocellular carcinoma; public health; CONTROLLED TEMPERATURE CHAIN; SUB-SAHARAN AFRICA; LIVER-CANCER; CHILDHOOD IMMUNIZATION; VIRUS-INFECTION; HOME DELIVERY; ELIMINATION; PREVENTION; PROGRAM; EPIDEMIOLOGY;
D O I：
10.3390/vaccines10050793
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Over 1.5 million preventable new hepatitis B infections continue to occur each year and there are an estimated 296 million people living with chronic hepatitis B infection worldwide, resulting in more than 820,000 deaths annually due to liver cirrhosis and hepatocellular carcinoma (HCC). Hepatitis B vaccination remains the cornerstone of public health policy to prevent HCC and a vital component of the global hepatitis B elimination response. The WHO has set a 90% vaccination target to achieve hepatitis B elimination by 2030; however, there is wide variability in reported birth dose coverage, with global coverage at only 42%. In this review, we outline the global trends in hepatitis B vaccination coverage and the impact of hepatitis B vaccination on HCC incidence and discuss the challenges and enabling factors for achieving WHO 2030 hepatitis B vaccination coverage targets.
引用
收藏
页数：16
相关论文
共 50 条
  • [1] Hepatitis B vaccination and prevention of hepatocellular carcinoma
    Kao, Jia-Horng
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (06) : 907 - 917
  • [2] Hepatitis B vaccination and hepatocellular carcinoma in Taiwan
    Lee, CL
    Ko, YC
    [J]. PEDIATRICS, 1997, 99 (03) : 351 - 353
  • [3] Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development
    Chemin, Isabelle
    [J]. FUTURE ONCOLOGY, 2010, 6 (01) : 21 - 23
  • [4] Prevention of Hepatocellular Carcinoma: Beyond Hepatitis B Vaccination
    Kim, Mi Na
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (02) : 316 - 328
  • [5] Vaccination against hepatitis B as prevention for hepatocellular carcinoma
    Dietz, Christopher A.
    Wedemeyer, Heiner
    [J]. ONKOLOGIE, 2022, 28 (01): : 15 - 22
  • [6] Vaccination against hepatitis B as prevention for hepatocellular carcinoma
    Dietz, Christopher A.
    Wedemeyer, Heiner
    [J]. ONKOLOGE, 2022, 28 (01): : 15 - 22
  • [7] Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls
    Chang, MH
    Shau, WY
    Chen, CJ
    Wu, TC
    Kong, MS
    Liang, DC
    Hsu, HM
    Chen, HL
    Hsu, HY
    Chen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (23): : 3040 - 3042
  • [8] Universal hepatitis B vaccination: The only way to eliminate hepatocellular carcinoma?
    Leroy, Vincent
    Asselah, Tank
    [J]. JOURNAL OF HEPATOLOGY, 2015, 63 (06) : 1303 - 1305
  • [9] Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
    Chang, MH
    Chen, CJ
    Lai, MS
    Hsu, HM
    Wu, TC
    Kong, MS
    Liang, DC
    Shau, WY
    Chen, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26): : 1855 - 1859
  • [10] The global impact of vaccination against hepatitis B: A historical overview
    Zanetti, Alessandro R.
    Van Damme, Pierre
    Shouval, Daniel
    [J]. VACCINE, 2008, 26 (49) : 6266 - 6273
12345